The recent identification of Streptococcus pseudopneumoniae (pseudopneumococcus) has complicated classification schemes within members of the "mitis" streptococcal group. Accurate differentiation of this species is necessary for understanding its disease potential and identification in clinical settings. This work described the use of the competence-stimulatory peptide ComC sequence for identification of S. pseudopneumoniae. ComC sequences from clinical sources were determined for 17 strains of S. pseudopneumoniae, Streptococcus pneumoniae, and Streptococcus oralis. An additional 58 ComC sequences from a range of sources were included to understand the diversity and suitability of this protein as a diagnostic marker for species identification. We identified three pherotypes for this species, delineated CSP6.1 (10/14, 79%), CSP6.3 (3/14, 21%), and SK674 (1/14, 7%). Pseudopneumococcal ComC sequences formed a discrete cluster within those of other oral streptococci. This suggests that the comC sequence could be used to identify S. pseudopneumoniae, thus simplifying the study of the pathogenic potential of this organism. To avoid confusion between pneumococcal and pseudopneumococcal pherotypes, we have renamed the competence pherotype CSP6.1, formerly reported as an "atypical" pneumococcus, CSPps1 to reflect its occurrence in S. pseudopneumoniae.
T he mitis group of streptococci includes nasopharyngeal colonizers such as Streptococcus mitis, Streptococcus oralis, Streptococcus pneumoniae, and the recently classified Streptococcus pseudopneumoniae (2) . Of these, S. pneumoniae (pneumococcus) is responsible for more than a million deaths annually and is responsible for diseases such as otitis media, pneumonia, septicemia, and meningitis. However, invasive diseases caused by other related viridans group streptococci had been documented (16, 26, 31) .
Some strains of S. pseudopneumoniae, along with S. mitis and S. oralis, have often been classified previously as "atypical pneumococci," because of their similarity to S. pneumoniae. These organisms share Ն99% identity in 16S rRNA gene sequences (2, 21, 43) . Optochin sensitivity and bile solubility, the two standard pneumococcal phenotypic identification tests, have proven to be inconclusive for differentiating pneumococci from these atypical strains (3, 4, 9, 10, 17, 19, 20, 22, 27, 29, 32, 34, 38, 39, 49) . Virulence factors that were once thought to be exclusive to the pneumococcus, such as pneumolysin (encoded by ply) and autolysin A (encoded by lytA), have been detected in commensal streptococcal species (18, 35, 49) , compromising their specificity as species identification markers. The pathogenic potential of S. pseudopneumoniae (the pseudopneumococcus) has been demonstrated in a murine model (12) as well as in humans (2, 18, 23, 24, 28, 40) . Rapid, correct identification of this organism in the clinical setting is essential for diagnosis and for understanding its disease potential. A simple, unequivocal method to identify S. pseudopneumoniae would be valuable.
Streptococci are competent for genetic transformation. In the case of S. pneumoniae, this is mediated by the competence-stimulatory peptide (CSP) encoded by the comC gene (13) . CSP sequences differ between species and within species; different versions within species are known as pherotypes (48) . We report the distribution of the comC sequence in strains of S. pseudopneumoniae and show that it may prove a valuable method to identify the organism rapidly.
MATERIALS AND METHODS
Clinical specimens and bacteria. A total of 17 clinical specimens of S. pseudopneumoniae, S. pneumoniae, and S. oralis were collected at the Royal Free Hospital Microbiology Laboratory between the years 1993 and 2010 (Table 1) . Sixteen samples were from patients with lower respiratory tract (LRT) infections, and a single strain was isolated from a normally sterile site. Samples were plated on Columbia blood agar (Oxoid, Cambridgeshire, United Kingdom) in 5% CO 2 at 35°C in an attempt to cultivate bacteria, and colonies suggestive of pneumococci based on morphology and alpha-hemolysis were tested for optochin sensitivity.
Genomic DNA extraction for amplification. Genomic DNA from LRT samples was extracted by a modified Chelex method as described previously (47) . The supernatant containing the DNA was used as the amplification template. For culture-positive clinical specimens, genomic DNA was extracted using the Wizard genomic DNA purification kit (Promega) or by the heat lysis method (30) . Presumptive identification of S. pseudopneumoniae. Quantitative PCR (qPCR) using primers and probes specific for Spn9802 (1, 44) and lytA (5) was performed sequentially to differentiate between S. pneumoniae (both positive) and S. pseudopneumoniae (Spn9802 positive, lytA negative). To monitor PCR inhibition, a SPUD potato gene internal amplification control (IAC) was included in each reaction using primers targeting phyB of Solanum tuberosum (36) . For lytA and Spn9802 qPCR assays, amplification reactions using 25-l mixtures containing 1ϫ Platinum quantitative PCR SuperMix-UDG (Invitrogen), a final concentration of 7 mM MgCl 2 , primers and probes, 4 ϫ 10 Ϫ7 M IAC template DNA (Sigma-Aldrich), and 5 l of template DNA (see Table S1 in the supplemental material) were performed. Negative and positive controls were performed for each qPCR assay. Amplification was performed using a Rotor-Gene Q (Qiagen) with the following conditions: an initial hold cycle at 95°C for 3 min, followed by 40 cycles of 95°C for 15 s and 60°C for 45 s. The PCR data were acquired at the end of each cycle and analyzed by the instrument software (Qiagen). Samples with cycle threshold (C T ) values Յ35 for the lytA or Spn9802 target were considered positive; samples that had no C T value for either the lytA or Spn9802 target but that did have a C T value Յ40 for the IAC target were considered negative, and samples with a no C T value for either the lytA or Spn9802 target and no C T value for the IAC target were considered inhibited. Samples positive for both lytA and Spn9802 were considered to be S. pneumoniae positives, and samples positive for Spn9802 and negative for lytA were considered to be presumptively S. pseudopneumoniae positive. All reactions were performed in triplicate.
Amplification of comC. Forward and reverse primers were designed to bind comC at positions 592 to 611 and 873 to 892, respectively (accession number U33315). The primer sequences and primer reaction concentrations are indicated in Table S1 in the supplemental material. For strains grown on agar, genomic DNA was extracted from bacterial cells from a fresh overnight culture on Columbia blood agar by the heat lysis method as described previously (30) . In addition to primers, each reaction mixture contained 2 l of template DNA, 0.3 l Taq polymerase (5 U/l) (Invitrogen), 1ϫ PCR buffer (10ϫ), 3 M MgCl 2 , and 0.6 mM deoxynucleoside triphosphates (dNTPs; Promega), made up to a final volume of 50 l with DNase/RNase-free distilled water (Gibco).
MLST. The primers used for multilocus sequence typing (MLST) have been described previously (8) . MLST was performed with the same reaction components and concentrations indicated for the comC amplification described above.
Amplicon purification and sequencing of comC and MLST loci. Amplicons were analyzed with 1.5% (wt/vol) agarose gel electrophoresis. Amplicons with the expected band sizes were purified using a PCR purification kit (Qiagen) according to the manufacturer's instructions. Cycle sequencing and sequence analysis were performed in the same manner for both PCRs (see below). Purified DNA was sequenced using BigDye Sequencing Terminator v.3.1 (Applied Biosystems), and sequences were analyzed on the 3130 genetic analyzer (Applied Biosystems) and viewed on Bionumerics software (version 5).
Publicly accessible sequences of streptococcal CSP. Additional streptococcal ComC amino acid sequences were included in this study for the construction of a phylogenetic tree (see below). Sequences obtained from previous publications, with accession numbers, are indicated in Table 1. Sequences for which no accession numbers are listed have not been deposited in GenBank. The sequences can be found in the sources given in Table 1 .
Construction of a comC phylogenetic tree. Multiple alignment of comC sequences was constructed with ClustalW functionality on MEGA version 5.05 (45) . For both analyses, neighbor-joining trees were constructed based on alignment data. Bootstrap support of 1,000 repetitions was performed.
RESULTS
S. pseudopneumoniae CSP sequences. It was possible to identify ComC sequences for nine pseudopneumococcal strains where CSP sequences were derived directly from samples submitted to our laboratory from patients with LRT and invasive infections. These samples were presumed to contain pseudopneumococci based on either Spn9802-positive and lytA-negative qPCRs (eight strains), bile insolubility and optochin-variable phenotypic traits (one strain, N452), or MLST (one strain, N452). The pherotype of the control strain, ATCC BAA-960, was also characterized in this study. Two pherotypes were detected in these nine strains, six (N452, RFH504, RFH543, RFH687, RFH905, RFH999) of which were associated with CSP6.1. To avoid confusion with pherotypes of other oral streptococci, we propose that CSP6.1 be named CSPps1, where "ps" represents the pseudopneumococcus. The three remaining strains, BAA-960, RFH686, and RFH827, had a ComC sequence that has not been reported before; this sequence is identical to that of CSPps1 in size, differing by an alanine-toserine substitution at position 12 of the propeptide. We propose that this pherotype be classified as CSPps2 (Fig. 1) . CSP sequences of four strains (IS7493, PT5479, PT5779, and SK674) were available from reports in earlier publications (25, 41, 48) . All but that of SK674 were identical to CSPps1. Thus, more than 70% of the presumptive S. pseudopneumoniae strains in this study were associated with CSPps1 (Table 2) . SK674 has an extended ComC of 54 amino acids, most similar to a pherotype characterized in Streptococcus infantis SK350, with six amino acid substitutions, three of which are in the mature peptide region (25) (Fig. 1 and Table 2 ).
Phylogenetic analysis of streptococcal pherotypes. A phylogenetic tree constructed from alignment of streptococcal pherotypes shows that, by pherotype, streptococci fall into two major groups (Fig. 2) . S. pneumoniae, S. pseudopneumoniae, S. mitis, and some S. oralis strains belong to one group (group 1), while a more divergent and loosely defined group (group 2) consists of predominantly Streptococcus gordonii, S. infantis, Streptococcus peroris, Streptococcus cristatus, and most of the remaining S. oralis strains. SK674, formerly classified as a pseudopneumococcus (25) , clustered near members of S. infantis by ComC alignment. All of the remaining S. pseudopneumoniae pherotypes are grouped in a separate cluster in close relation to other species, notably S. oralis and S. mitis (Fig. 2) .
DISCUSSION
We have characterized pherotypes associated with S. pseudopneumoniae by comparing strains available to us, amplifying sequences collected from lower respiratory tract samples and collecting publicly available ComC sequences for this organism and related streptococcal species. We have shown that CSP6.1 (or CSPps1) is the commonest pherotype among S. pseudopneumoniae strains found in different geographical regions. Pherotype CSP6.1 was previously considered to be a rare pherotype of an "atypical nontypeable pneumococcal" strain, 874, based on multilocus sequence analysis (33, 48) . Its classification as a pneumococcus may stem from its possession of ply and lytA, which were once considered suitable genetic markers for this organism (33) . However, it is known that these two genes are not specific to S. pneumoniae (18, 35, 49) , and we have been unable to find a report of CSP6.1 being found in a strain unequivocally identified as S. pneumoniae. Based on these observations, we hypothesize that strain 874 is a strain of S. pseudopneumoniae. Pneumococcal strain 101/87, associated with CSP5, was described as an "atypical pneumococcus" and could not be serotyped by Whatmore et al. (48) , and this strain is most likely to be S. pseudopneumoniae. Phylogenetic analysis of CSP sequences in this study suggests that CSP5 is most closely related to S. mitis or S. oralis pherotypes that cluster together. Thus, we believe that CSP6.1 is associated with S. pseudopneumoniae and that, to differentiate pseudopneumococcal pherotypes from ComC sequences from other organisms, they should be designated CSPps1 instead of CSP6.1.
In this study we have identified a new pherotype associated with S. pseudopneumoniae and have designated this CSPps2. S. pseudopneumoniae pherotypes form a distinct cluster within those of other oral streptococcal species, suggesting that pseudopneumococcal pherotypes could be species specific and could be used as a simple diagnostic tool.
In contrast, strain SK674, a S. pseudopneumoniae strain identified based on clustering of housekeeping gene sequences (25) , clustered closely in ComC sequences of S. infantis strains. One might argue that SK674 acquired a divergent comC from S. infantis by horizontal gene transfer. While interspecies transfer of the competence operon has been documented (15), the lack of such an event in our collection of over 200 pneumococcal strains indicates that this is relatively rare (our unpublished data). SK674 has a genome size of 1.87 Mbp (25) , comparable to those of other S. infantis strains (1.74 to 1.88 Mbp) and much smaller than the genome size of the pseudopneumococcal strain IS7493 (2.1 Mbp) (40) . It seems that the alternative explanation, that SK674 is actually a strain of S. infantis, is more likely. Additional analysis of SK674, such as DNA-DNA hybridization and lytA sequence analysis, may shed light as to the true identity of this strain.
From the recently characterized genome sequence of S. pseudopneumoniae strain IS7493, it was concluded that CSP-mediated induction of fratricide does not take place based on the absence of comC in this strain (40) . We were, however, able to locate the gene that is identical to that of CSPps1. Thus, we can conclude that this S. pseudopneumoniae strain does contain the necessary gene sequences for production of a competence peptide and that a homologous gene is found in all pseudopneumococcal strains analyzed thus far, strengthening the use of this gene as a diagnostic marker. (2) . These tests can be difficult to standardize in the laboratory. Identification by comC sequencing would allow a rapid method of definitive diagnosis as the competence ligand gene is conserved across streptococcal species and the pseudopneumococcal comC sequences appear to provide taxonomic information, similar to the case of gyr in Serratia species (6) . Previously reported genetic approaches to differentiate S. pseudopneumoniae from S. pneumoniae relied on targeting lytA, cpsA, aliB-like ORF2, ply, psaA, Spn9802, and sodA (2, 5, 7, 16, 24, 37, 42, 44) ; however, these are inconclusive. While multilocus sequence analysis can reveal divergence between species by their housekeeping and virulence gene fragments (11, 25) , these methods are too cumbersome for large-scale and routine clinical diagnosis. Recent accounts of detection of pseudopneumococcus in carriage and symptomatic hosts with antibiotic resistance necessitate its accurate diagnosis as an emerging causative agent of disease (23) . A recent report suggested that sequencing recA could differentiate between S. pneumoniae and S. pseudopneumoniae (43) , but the study was performed with a smaller number of pseudopneumococcal strains solely from North America. Here we propose that pherotyping may be a promising diagnostic alternative based on the clustering of pseudopneumococcal pherotypes from different continents.
In conclusion, we propose that CSP sequence analysis can provide rapid accurate differentiation of S. pseudopneumoniae from closely related species S. pneumoniae, S. mitis, and S. oralis. With this in mind, we anticipate that some strains currently classified as atypical pneumococci can be identified as pseudopneumococci based on ComC sequencing. Use of ComC sequencing will simplify the gathering of data to understand the disease potential of this organism, which may be now emerging as a pathogen. To add to this observation, we would encourage other laboratories to sequence "atypical pneumococcal" strains to provide more sequences to confirm whether ComC may be used as a rapid marker for the identification of this emerging pathogen.
